Study bolsters case for breast MRI screening

Article

Breast MRI is far superior to x-ray mammography for picking up ductal carcinoma in situ generally and for spotting high-grade early-stage disease, according to Dr. Christiane Kuhl and colleagues at the University of Bonn.

Breast MRI is far superior to x-ray mammography for picking up ductal carcinoma in situ generally and for spotting high-grade early-stage disease, according to Dr. Christiane Kuhl and colleagues at the University of Bonn.

They enrolled 7319 women who underwent mammography and MRI in a screening setting. Of these, 167 received both imaging tests preoperatively and had a biopsy-proven diagnosis of DCIS without associated invasive breast cancer. Mammography detected 56% and MRI detected 92% of all DCIS. MRI detected 98% of high-grade lesions compared with 52% for mammography (Lancet 2007;370:485-492).

An editorial in the same issue suggested MRI should no longer be seen as an adjunct to mammography but as a screening modality in its own right. Study authors warned against quick conclusions, however, noting that few radiologists can offer MRI with the level of expertise required for diagnostic mammography.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.